Psilocybin to Treat Depression in Spinal Cord Injury
Recruiting
Phase 1
Phase 2
Interventional Study
Spinal Cord Injury
Depression - Major Depressive Disorder
Veteran
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 22 and older
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- James J. Peters Veterans Affairs Medical Center · Federal
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main goal of this study is to determine if psilocybin is safe for use in people with SCI. The study will measure how people with SCI respond to three psilocybin doses: low (5mg), medium (10mg), and high (25mg).
The main question the study aims to answer is: does psilocybin increase the number and severity of adverse (bad) events reported by people with SCI? These may include pain, muscle spas…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Able and willing to provide informed consent
* Spinal cord injury for at least 1 year
* Confirmed diagnosis of depression
* At least 22 years of age at time of consent
* At least 50 kg (110 lbs.) body weight
* Fully independent from ventilatory support (ventilator or diaphragm…
Contacts